UM Brain Cancer Vaccine: Ferritin FIT for Glioblastoma
Discover University of Macau's revolutionary ferritin-based in situ vaccine for glioblastoma, achieving 50%+ survival in models via meningeal lymphatic delivery.
research-publication-newsuniversity-of-macauglioblastoma-vaccine
